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Abstract
Background: The pathology of diabetic neuropathy involves oxidative stress on pancreatic b-cells, and is related to
decreased levels of Insulin-like growth factor 1 (IGF-1). Acylated steryl b-glucoside (PR-ASG) found in pre-germiated brown
rice is a bioactive substance exhibiting properties that enhance activity of homocysteine-thiolactonase (HTase), reducing
oxidative stress in diabetic neuropathy. The biological importance of PR-ASG in pancreatic b-cells remains unknown. Here
we examined the effects of PR-ASG on IGF-1 and glucose metabolism in b-cells exposed to oxidative stress.
Methodology/Principal Findings: In the present study, a pre-germinated brown rice (PR)-diet was tested in streptozotocin
(STZ)-induced diabetic rats. Compared with diabetic rats fed control diets, the PR-diet fed rats showed an improvement of
serum metabolic and neurophysiological parameters. In addition, IGF-1 levels were found to be increased in the serum, liver,
and pancreas of diabetic rats fed the PR-diet. The increased IGF-1 level in the pancreas led us to hypothesize that PR-ASG is
protective for islet b-cells against the extensive injury of advanced or severe diabetes. Thus we examined PR-ASG to
determine whether it showed anti-apoptotic, pro-proliferative effects on the insulin-secreting b-cells line, INS-1; and
additionally, whether PR-ASG stimulated IGF-1 autocrine secretion/IGF-1-dependent glucose metabolism. We have
demonstrated for the first time that PR-ASG increases IGF-1 production and secretion from pancreatic b-cells.
Conclusion/Significance: These findings suggest that PR-ASG may affect pancreatic b-cells through the activation of an IGF-
1-dependent mechanism in the diabetic condition. Thus, intake of pre-germinated brown rice may have a beneficial effect
in the treatment of diabetes, in particular diabetic neuropathy.
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Introduction
Dietary intake of pre-germinated brown rice (PR) (Hatsuga
genmai) [1] has widely been found useful for alleviating symptoms
of both diabetes and pre-diabetes. Previously we demonstrated
that intake of a PR-containing diet decreased the severity/
frequency of hyperglycemia in streptozotocin (STZ)-induced
diabetic rats [2]. Later it was demonstrated that the beneficial
effects of the PR-diet were due to the germination process, which
was considered contributory to development of the intrinsic
potential to elevate the activities of protective enzymes that
respond to oxidative stress in diabetic neuropathy [3]. One such
known stress is an increase in homocysteine (Hcy), which is
elevated in diabetes [3], and undergoes intra-molecular thiolac-
tone formation.
Acylated steryl b-glucoside (ASG) is a glycolipid that is
ubiquitously distributed in edible plant sources [4]. We revealed
that germination of brown rice led to de novo production of a
special lipid ingredient, PR-derived ASG (PR-ASG), as purified
from the bran of PR [5]. PR-ASG was found to be a bioactive
substance that enhances the activities of the enzyme Hcy-
thiolactonase (HTase) to decompose Hcy-thiolactone and decrease
severity of oxidative stress and diabetes. This enhancing activity
has thus far been demonstrable only for PR-ASG and has not been
shown for any other ASGs contained in plant seeds.
It is unclear how PR-ASG is related to the anti-oxidative activity
of the PR-diet. PR-ASG may possess unknown and protective
activity for diabetes beyond the oxidation defense provided by
activation of HTase. It is also unclear whether PR-ASG may for
example up-regulate the b-cells self-anti-apoptosis machinery,
enabling b-cells to rescue themselves from oxidative stress and cell
death by diabetes. Oxidative stress occurs secondary to an increase
in the level of Reactive oxgen species (ROS), which is controlled
primarily by the defense system against oxidative stress in b-cells.
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and antioxidant defense in the b-cells. The overall effect of the
antioxidant system depends on the intracellular balance between
these antioxidant enzymes [6]. The mechanism for maintaining
that enzymatic balance involves glucose-6-phosphate dehydroge-
nase (G6PD). The function of G6PD is to maintain the cellular
ratio of NADPH/NADP and up-regulate its own activity in the
pentose phosphate pathway relevant to the cell apoptotic response
to ROS [7,8].
Glucose is implicated as being a regulatory molecule for
inducing b-cells to induce secretion of insulin and insulin-like
growth factor 1 (IGF-1). It is known that this glucose-dependent
IGF-1 activation system is closely coupled to glucose metabolism
including the glycolytic pathway, and the pentose phosphate
pathway [8,9,10]. For example, activation of the glucose-
dependent IGF-1 activation system subsequently enhances the
glycolytic pathway for cell proliferation [8]. It is well known that
each of these pathways can be blocked by specific inhibitors: 6-
aminonicotinamide (6-AN) for the pentose phosphate pathway,
and 2-deoxyglucose (2-DG) for the glycolytic pathway [11,12].
In the present study we focused on IGF-1 in pancreatic islet b-
cells, since IGF-1 activity also is intimately related to development
of diabetic neuropathy. The relationship of diabetic neuropathy to
various growth factors has been extensively studied [13]. In
particular, IGF-1 is known to be decreased in serum of rats with
diabetic neuropathy [14,15].
In order to examine the relationship between PR-ASG and
IGF-1, we determined how PR-ASG affects IGF-1 levels of serum,
pancreas, and liver in STZ-diabetes rats fed PR diet. Subsequently
we used an islet b-cell line (INS-1) to examine replication and
apoptosis of b-cells, which are involved in hyperglycemia-induced
oxidative stress in diabetes [10,14]. Our data suggests that PR-
ASG enhances IGF-1 production in STZ-diabetic rat islet b-cells
and INS-1 cells by the same mechanism. To understand this
action of PR-ASG, we analyzed the effects that it had on two
systems for defense against oxidative stress. The first system is the
IGF-1-related pentose phosphate/glycolytic pathways; this system
was analyzed with the specific inhibitors 6-AN and 2-DG. The
second is the PR-ASG-sensitive HTase-related anti-oxidation
system.
Materials and Methods
Ethics statements
The use of these animals was approved by Georgia Health
Sciences University’s Institutional Animal Care and Use Com-
mittee (protocol# 06-08-828).
Experimental diets
Pre-germinated brown rice (PR) and white rice (WR), both of
the Japonica species, were used in the study. PR was prepared at
25–30% water content to induce germination and dried to 15%
according to a patented procedure (Patent No. 3738025, Jp,
November 4, 2005).
PR and WR were manufactured as powdered feed by Harlan
Teklad (Madison, WI). The control diet (AIN93G) was composed
of cornstarch [39.7% (w/w)], a-cornstarch [13.2% (w/w)], casein
[20.0% (w/w)], L-cysteine [0.3% (w/w)], sucrose [10% (w/w)],
soybean oil [7.0% (w/w)], cellulose powder [5.0% (w/w)], mineral
mix [3.5% (w/w)], vitamin mix [1.0% (w/w)], choline bicitrates
[0.25% (w/w)], and butylhydroquinone [0.0014% (w/w)]. PR and
WR diets were produced by replacing cornstarch and a-cornstarch
with the respective powders as a source of carbohydrates. The
energy content range was 370.0 to 390.0 kcal/100 g diet, with no
total energy difference between the experimental diets.
STZ-induced diabetic rats and experimental diets
Male Wistar rats weighing 120–140 g received intra-peritoneal
injections of STZ (65 mg/kg in 100 mM sodium citrate buffer,
pH 4.5) and were maintained on control diet (AIN93G) for 2
weeks. Two animals were housed per cage in a controlled
environment. All animals were allowed free access to water and
feed.
Only those animals whose blood glucose levels were .400 mg/
dl were diagnosed as diabetic. The diabetic rats (n=24) were
divided into three diet-feeding groups: AIN93G (n=8), WR
(n=8), and PR (n=8). Non- diabetic, control rats (n=18) were
also divided into the same three diet-feeding groups: AIN93G
(n=6), WR (n=6), and PR (n=6). The substitution of control diet
with experimental diet was performed at 2 weeks after STZ
injection and continued for 3 weeks. Food consumption was
measured by weighing the feeding containers daily. Beginning 1
week after STZ injection, blood samples were obtained at
predetermined time points (0, 1, 2, 3, 4, and 5 weeks) from the
same rats following a 15-hour starvation period. Blood was
obtained by pricking the tip of the rat tail and collecting a drop
(about 0.06 ml) of blood. The glucose levels in these blood samples
were measured using a strip-operated blood glucose meter (Accu-
Chek Advantage Blood Glucose Meter, Roche Diagnostics,
Indianapolis, IN). When the blood glucose level was higher than
the range of the instrumental system, the serum glucose level was
assessed by Glucose (GO) Assay Kit (GAGO-20, Sigma, St. Louis,
MO). Three weeks after initiation of the experimental diets, nerve
conduction studies were performed in the rats’ tails to assess
electrophysiological function, after which the rats were anesthe-
tized. Whole blood was obtained from each rat by cardiocentesis
at the endpoint of the experiment, and serum samples were
obtained for biochemical analyses, as described below.
NCV measurements
Nerve-conduction velocities (NCVs, m/sec) were assessed in the
rat tail nerve using a Nicolet Viking Quest EMG machine
(Neurocaregroup, Madison, WI) according to the modified
procedure of Anderson et al. [16]. In summary, the tail nerves
were stimulated using external digital ring electrodes with flexible
wires (Medtronic Functional Diagnostics, Skovlunde, Denmark) in
place of needle electrodes [3]. The electrodes were attached to the
tail segments 5 cm proximal and 2 cm distal to the recording
position (7-cm distal from the joint of the rat’s tail). Blood was then
collected from the distant tip of the tail that was non-interactive
with NCV measurement. Electrical stimulation of each rat
generated four different waves, from which NCV was evaluated
under the condition that every wave showed a reproducible
latency and amplitude as the voltage of the stimulation was
increased. During each measurement, the surface temperature of
the rat’s tail was maintained (34–35uC). Four nerve conduction
waves were measured per animal; the NCV values were corrected
for monitor variations in temperature and expressed as an average
value.
Serum metabolic parameters in animal experiments
Homocysteine (Hcy), high density lipoprotein-cholesterol
(HDL-C), and low density lipoprotein-cholesterol (LDL-C) were
respectively measured by the following commercial assay kits from
Diazyme Laboratories (San Diego, CA): HDL-Cholesterol Test
Kit; LDL-Cholesterol Test Kit; Homocysteine Assay Kit. HTase
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from Alfresa Pharma Corp. (Osaka, Japan) [17].
Measurement of IGF-1 and insulin
For IGF-1 assay, liver and pancreas tissue from each rat was
rinsed with phosphate buffered saline (PBS), and homogenized in
PBS solution (20% w/v) and stored overnight at 240uC. After two
freeze-thaw cycles, the homogenates were centrifuged for 5 min at
5,0006g. The tissue supernatants were immediately collected and
frozen before use in IGF-1 assay. Serum samples also were
immediately collected and frozen before use for the IGF-1 and
insulin assay. An immunoassay kit that is able to recognize rat/
mouse IGF-1 (QuantikineH, R&D Sysetm, Inc., Minneapolis, MN)
was used to quantify IGF-1 in serum and tissue supernatant from
each rat. Serum insulin was measured by suing Rat/Mouse Insulin
ELISA kit (Millipore, Billerica, MA).
Purification of PR-ASG for in vitro experiments
Using the procedure detailed by Folch [18], a total lipid fraction
was prepared from bran of PR by successive extraction of 5 g
samples with 30 mL of chloroform-methanol [1:1(v/v)] and
20 mL of chloroform-methanol [2:1(v/v)]. The lipid extracts were
combined, evaporated, and subjected to silica gel column
chromatography (Iatrobeads, 6RS-8060, Iatron, Tokyo, Japan)
according to a previously described method [5].
PR-ASG was analyzed by thin-layer chromatography on a high
performance thin layer chromatographic plate (HPTLC) that was
developed using a solvent system of chloroform-methanol-water
(65:35:8; v/v/v). It was judged to be homogeneous, as revealed by
a single spot upon visualization using the orcinol-sulfuric acid
reagent.
Subsequently, the activity of the purified PR-ASG in HDL
fractions from non-diabetic male Wistar rats was tested for HTase
using an Alfresa auto HTLase assay kit (Alfresa Pharma Corp.,
Osaka, Japan).
For cell experiment PR-ASG was dissolved in RPMI 1640
medium containing 0.1% bovine serum albumin (fatty acid-free
and low endotoxin, Sigma, St. Louis, MO, USA).
Cells
The parental INS-1 cell line was established from a rat
insulinoma by Asfari et al [19]. Cells were maintained at 37uC
in an atmosphere of 5% CO2 and 95% air with RPMI 1640
medium containing 10% fetal bovine serum supplemented with
10 mM HEPES, 1 mM sodium pyuruvate, 50 mM2 9-mercapto-
ethanol, penicillin (100 units/mL), and streptomycin (100 mg/mL).
Cells were subcultured to 70–80% confluence [19].
Cell proliferation/toxicity and released IGF-1/insulin
levels
Cells (5610
4 in 200 mL per well) were seeded into a 96-well
micro plates coated with poly-L-ornithine (0.001%) in 10% serum-
RPMI 1640 medium. After 24 hours incubation, the cells were
washed twice with serum-free medium, and then exposed for 1 hr
to 1 mM STZ in the serum-free medium, either in the presence or
absence of PR-ASG (0–400 mg/mL). Subsequently, the cells were
washed twice more, and cultured for 2 days at 37uC with serum-
free medium containing between 0 and 400 mg/mL PR-ASG.
Following culture, cell viability testing was performed by using cell
counting kit-8 (CCK-8, Dojindo, MD, USA); and an IGF-1
immunoassay kit (QuantikineH, R&D Sysetm, Inc., Minneapolis,
MN) was used to measure IGF-1 released into the cultured
medium. In order to induce insulin secretion, cells were washed
Krebs-Ringer buffer pH 7.4 (119 mM NaCl, 4.75 mM KCl,
2.54 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4,5 m M
NaHCO3, 20 mM HEPES, pH 7.4) and exposed to low glucose
(2 mM) buffer medium and high glucose (12 mM) buffer medium
for 1 hr. Insulin determination was performed on the incubation
medium using Rat/Mouse Insulin ELISA kit (Millipore, Billerica,
MA).
TUNEL assay and nuclear staining of INS-1 cells
Cells were cultured on glass coverslips, and then exposed to
1 mM STZ in serum-free medium for 1 hour. The cultured cells
were then divided into serum and ASG groups, and respectively
supplemented with either serum (0 and 10%) or PR-ASG (4 and
400 mg/mL). Subsequently, cells were cultured for 2 days in fresh
serum-free medium and supplemented with either serum (0 and
10%) or PR-ASGs (4 and 400 mg/mL), respectively. After pre-
washing 3 times with PBS, cells were fixed with 4% paraformal-
dehyde/PBS solution. They were then permeabilized at 37uC for
1 hour with 100 mL TUNEL mixture (Roche, Mannheim,
Germany). The cells were again washed with PBS, followed by
staining with 49,6 9-dianidino-29-phenylindole diHCl (DAPI;
1 mg/mL; Sigma) in the dark for 30 min. After a final washing
of the cells, the coverslips were mounted on glass slides and
examined under a fluorescent microscope (Nikon Eclipe TE300,
Nikon Instruments, Melville, NY).
mRNA expression of IGF-1 in INS-1 cells
Cells (1.0610
7) were seeded in 10 mL of 10% serum-RPMI
1640 medium on a 100-mm dish that had been precoated with
poly-L-ornithine (0.001%). One day later, the cells were washed
twice with serum-free medium and pre-incubated at 37uC in this
medium supplemented with 10% serum or varying quantities of
PR-ASG (4 and 8 mg/mL, respectively). Two days later, the cells
were washed with 2 mL of PBS twice and then harvested for RNA
preparation.
Total cellular RNA was isolated using NucleoSpinH RNA II Kit
(Marcherey-nagel, Du ¨ren, Germany) and quantitated at wave-
length 260 nm on a spectrophotometer (Beckman Coulter Inc.,
Fullerton, CA). The isolated total RNA was then converted to
cDNA using Superscript III First-strand Synthesis System
(Invitrogen, CA), following the protocol supplied by the manufac-
turer. The PCR conditions were 94uC denaturation for 20 sec,
followed by 60uC annealing for 20 sec, and then 72uC extension
for 40 sec for 26–38 cycles. Gene expression was described as
positive or negative expression in relation to the ‘housekeeping’ b-
actin gene. The PCR products were analyzed by 2% agarose gel
electrophoresis. The sequences of the primers used for the gel were
as follows: IGF-1 sense (59- CTGCTTGCTCACCTTTACCA -
39), IGF-1 antisense (59- GCTCAAGCAGCAAAGGATCT -39),
b-actin sense (59- ACGGTCAGGTCATCACTATCG -39), and
b-actin antisense (59- GCTCAAGCAGCAAAGGATCT -39).
Glucose utilization in INS-1 cells
Cells (5610
4 in 200 mL per well) were seeded into 96-well micro
plates coated with poly-L-ornithine (0.001%) in RPMI 1640
medium containing 10% serum. One day later, the cells were
washed twice with serum-free medium, followed by exposure for
1 hr to either 1 mM STZ or no STZ, in serum-free medium
containing either 0 or 4 mg/mL PR-ASG. Subsequently, cells were
pre-washed twice with Krebs Ringer buffer (pH 7.4). They were
then exposed for 1 day to 0.1 mM glucose and 0–300 ng/mL
IGF-1(Recombinant Rat Insulin-Like Growth Factor 1, #CR117;
Cell Sciences Canton, MA) in Krebs Ringer buffer, containing 0–
10 mM 2-deoxy-glucose (2-DG; Sigma) and either 0 or 4 mg/mL
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examined for glucose utilization using Glucose (GO) Assay Kit
(GAGO-20, Sigma). . This glucose utilization was less than
1.0 nmol/hr/10
6 cells at zero concentration of IGF-1. A percent
value denotes that 100% is equal to 16.7 nmol/hr per 10
6 cells.
The cell numbers were normalized using values measured during
collection of the supernatants.
Glucose-6-phosphate dehydrogenase (G6PD) activity in
INS-1 cells
Cells (2.5610
5 in 1 mL per well) were seeded into 12-well plates
coated with poly-L-ornithine (0.001%) in 10% serum-RPMI 1640
medium. One day later, the cells were pre-washed with serum-free
medium, and treated by the following procedure: 1) the cells were
exposed for 24 hours to the presence (4 mg/mL) or the absence
(0 mg/mL) of PR-ASG in either the RPMI medium containing 0–
100 mM 6-AN or the RPMI medium containing no folic acid and
between 0–50 mM Hcy; and 2) the cells were exposed for 1 hr to
either 1 mM STZ or no STZ, in serum-free medium containing
either 0 or 4 mg/mL PR-ASG, followed by pre-washing with fresh
medium and treated for 30 min at 37uC with serum-free RPMI-
1640 medium containing 0–32 mM glucose and 4 mg/mL PR-
ASG.
In both of the above procedures, cells were harvested and
sonicated for 1 min in 50 mM Tris-HCl buffer (pH 7.2). The
supernatants were collected in micro-centrifuge tubes and
normalized based on the relationship between protein amount
and cell number. The enzyme reaction mixture was composed of
10 mL of the supernatant and 90 mL of the following solution:
50 mM Tris-HCl buffer (pH 7.2) containing 2.5 mM glucose-6-
phosphate; 0.2 mM NADP; 0.2 mM 1-methoxy-phenazine meth-
osulfate; and 5 mM WST-8; tetrazolium salts, Sigma). This
reaction mixture was incubated for 30 min at 37uC, followed by
colorimetric measurement at 450 nm with a reference at 595 nm.
Measurement of total ROS in INS-1 cells
Total ROS level was detemined using 29,7 9-dichlorodihydro-
fluorescein diacetate (DCF-DA) (Sigma). Cells were seeded into
96-well microtiter plates (white plate with clear bottom, Corning)
in RPMI 1640 medium containing 10% serum. One day later, the
cells were pre-washed twice, and treated for 1 hour with 1 mM
STZ. Subsequently, cells were pre-washed with PBS, and
incubated with DCF-DA (1.0 mM) in darkness for 10 min. DCF-
DA green fluorescence was assessed under a fluorescent micro-
scope (Nikon Eclipe TE300, Nikon Instruments, Melville, NY) and
quantitated by a Perkin-Elmer Victor V multilabel plate reader
with excitation/emission filters set at 490 and 535 nm.
Measurement of HTase activity in INS-1 cells
Cells (2.5610
5 in 1 mL of 10% serum-containing RPMI
medium per well) were cultured in12-well plates. One day later,
the cells were exposed for 1 hr to 1 mM STZ with either 0 or
4 mg/mL of PR-ASG, in RPMI 1640 medium, containing 1.0 mg/
mL low density lipoprotein (LDL), prepared from rat by our
method as previously reported [3]. Subsequently, the cells were
washed and treated for 24 hr in serum-free RPMI-1640 medium
containing either 0 or 4 mg/mL of PR-ASG. Cells were then
harvested and sonicated for 1 min in PBS buffer, and the
supernatants were collected in micro-centrifuge tubes. The cellular
supernatant was added to an Alfresa auto HTLase assay kit
(Alfresa Pharma Corp., Osaka, Japan). The initial rate of
hydrolysis was determined spectrophotometrically by monitoring
absorbance at 450 nm both 0 and 10 min after substrate addition.
One unit of HTase activity is equal to the amount of 1 nmol HT
that is hydrolyzed in 1 minute by 1 mg of protein.
Statistical analysis
Statistical analyses were performed using the GraphPad Prism
5.0 software package (GraphPad, San Diego, CA, U. S. A.). The
various parameters evaluated in our animal experiments were
analyzed using the one-way ANOVA, followed by Tukey’s
multiple comparison test and Dunnet’s test (Table 1). The
influences of PR-ASG in cell experiments was analyzed for
statistical differences using either one-way ANOVA followed by
Tukey’s and Dunnet’s test, or two-way ANOVA followed by
Bonferroni’s post-test.
Results
PR-ASG
The current lot of PR-ASG used in our cell experiment was
tested for HTase activity according to a commercial assay kit for
HTase (Alfresa Auto HTLase; Alfresa, Osaka, Japan). HTase
activity was quantitated by measuring hydrolysis of the substrate,
c-thiobutyrolactone, along with either 100 mg of rat HDL fraction
in the presence of 1.0 mg of PR-ASG, or 100 mg of rat HDL
fraction in the absence of PR-ASG. Purified PR-ASG clearly
showed a stimulatory effect on HTase activity, at 0.01 to 1.0 mg.
This increase with addition of PR-ASG reflects up to 160% of
enhancement (16.460.52 nmol/min) as compared with HTase
activity in the absence of PR-ASG (10.460.32 nmol/min). For 6
different measurements of HTase activity level, the resulting values
were presented as mean6SEM and showed a statistical difference
(p,0.01).
Body weight and blood-glucose level in rats
An animal experiment was performed on STZ-induced diabetic
rats in order to examine the effect of PR-diet. During the 3-week
experimental feeding period the rats’ food consumption rate (g per
day) showed no difference in food intake between normal and
diabetic rats.
No difference in weight gain was observed in normal rats fed
any of 3 varying diets (WR-, PR-, and AIN93G). Nor did diet type
appear to effect weight gain in the diabetic rats; however, overall
weight gain was suppressed in the diabetic rat population (Table 1),
as we have previously reported [3]. This is considered to be a well-
established phenomenon observed in insulin-deficient rats after
STZ treatment [20].
The blood-glucose levels of the non-diabetic rats on all 3 diets
(WR, PR, and AIN93G) were within the normal range during the
experimental period (Table 1). In contrast, the blood-glucose levels
of the diabetic rats were elevated; however, the blood glucose
levels of diabetic rats on the PR diet were significantly lower than
those fed the AIN93G and WR diets (p,0.01, Dunnet’s test).
Neurophysiological parameter and serum metabolic
parameter and in rats
To evaluate the effect of the PR-diet on diabetic neuropathy,
serum metabolic parameters and nerve conduction velocity (NCV)
were measured. The effect of the various diets on NCV is shown in
Table 1, expressed as means 6 SEM. Diabetic rats fed all 3 diets
showed significantly decreased NCVs when compared with the
NCVs of the non-diabetic rats. Within the diabetic rat population,
however, NCVs in PR-diet treated rats were significantly
improved as compared with NCVs in rats fed AIN93G and
WR-diets.
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groups of rats. Control diet (AIN93G) feeding in STZ-treated rats
showed abnormality of serum parameters specific to diabetes; but
non-diabetic rats showed normality of serum parameters. There
was no difference of serum parameters between control diet and
two experimental diets in non-diabetic rats. In the diabetic rat
population, on the other hand, when those fed the AIN93G and
WR diets were compared to those fed the PR-diet, the former
group showed a statistically significant increase in both Hcy level
and HTase activity(**p,0.01). Because the diabetic rats were
accompanied by an increase in creatinine level, the decreased Hcy
level may be attributed to renal insufficiency, such as occurs in
diabetic nephropathy (data not shown). However, we found that
the Hcy level could normalize in diabetic rats fed the PR diet.
Serum cholesterol-balance resulted in an increase in LDL-C
and a decrease in HDL-C in diabetic rats fed the AIN93G and
WR diets, compared to the non-diabetic rats. Contrary to the
diabetic rats fed the AIN93G and WR diets, the diabetic rats fed
the PR diet showed statistically significant normalization of LDL-
C and HDL-C levels.
IGF-1 and insulin levels in rats
Serum insulin levels were significantly reduced in diabetic rats
treated with AIN93G diet compared with non-diabetic rats
(Table 1). However, the PR-diet-treated diabetic rats showed
increased insulin levels compared with diabetic rats treated with
AIN93G- and WR-diets (**p,0.01). IGF-1 levels in rat serum,
pancreas and liver samples are shown in Table 1. All 3 control
(non-diabetic) groups had IGF-1 levels as follows: serum levels
around 950 ng/mL; pancreas and liver levels around 150 and
238 ng/g tissue, respectively. In contrast, diabetic rats fed the
AIN93G and WR diets showed a marked decrease in serum IGF-1
levels (160.9 and 167.8 ng/mL), liver (85.9 and 92.0 ng/g tissue),
and pancreas (51.1 and 65.3 ng/g tissue). As compared with
AIN93G diet, diabetic rats fed the PR diet showed a statistically
significant rebound in IGF-1 levels in serum (from 160.9 to
607.3 ng/mL, **p,0.01), pancreas (from 51.1 to 120.1 ng/g
tissue, **p,0.01), and liver (from 85.9 to 165.1 ng/g tissue,
*p,0.01). Above all, remarkable was the IGF-1 enhancement in
the pancreas. In contrast non-diabetic rats on the PR-diet did not
show any significant rebound in the pancreas IGF-1 level as
compared with AIN93G and WR diets.
Cell toxicity and apoptosis in INS-1 cells
To determine the effect of PR-ASG on cell growth and death of
b-cells, INS-1 cells were cultured in medium with 10% serum.
These cells showed better viability, increasing in number by about
140% as compared with those grown in serum-free medium
(Fig. 1A). On the other hand, pre-treatment with STZ decreased
cell viability remarkably due to the toxicity of STZ. However, 10%
serum was found to be protective against STZ toxicity and
improved cell viability up to 55.1% of that of control. The
decrease in the number of viable, STZ treated cells was analyzed
using a cell apoptosis assay with TUNEL, and nuclear staining
with DAPI (Fig. 1C). We found that STZ induced INS-1 cell
apoptosis, but that 10% serum was protected against said
apoptosis.
PR-ASG (at 1 and 4 mg/mL) enhanced INS-1 cell proliferation,
although we did not find statistically significant differences from
the control group (Fig. 1B). A high concentration of PR-ASG
(400 mg/mL) showed some toxicity, by causing cell detachment
from the plate as shown in picture ASG1 of Fig. 1C. Contrarily, a
low concentration of PR-ASG (4 and 8 mg/mL) was protective
against cell apoptosis secondary to STZ treatment (Fig. 1B and C).
IGF-1 release into the culture medium and mRNA
expression of IGF-1
The effect of PR-ASG on IGF-1 production was examined
using INS-1 cells. As shown in Fig. 2A, IGF-1 secretion did not
occur in STZ-negative medium (first non-shaded column), but
addition of PR-ASG to the STZ-negative medium stimulated IGF-
1 secretion in a dose-dependent manner (0.4 to 8 mg/mL),
increasing up to more than 500 pg/mL of IGF-1. On the
contrary, very little IGF-1 was secreted for STZ-treated cells at
any concentration of PR-ASG presumably because STZ induced
cell apoptosis.
Table 1. Final body weights, blood glucose concentrations, and serum parameters in non-diabetic and diabetic rats (3 weeks).
Treatment Non-diabetic Diabetic
Diet AIN93G WR PR AIN93G WR PR
Numbers of animals 6668 88
Weight (g) 370.1610.5 362.3611.4 356.2611.4 174.5615.1 182.2617.8 213.8621.8
Blood Glucose(mg/dl) 107.3619.0 106.2620.1 112.3612.1 457.3638.1 425632.1 301.2632.7**
NCV (m/s) 50.161.2 48.961.2 49.861.3 35.161.5 34.962.0 45.061.3***
Hcy (uM) 5.160.5 5.160.2 5.160.3 2.460.6 2.260.4 4.760.5**
HTase (nml/mg/min) 8.360.5 8.660.2 9.160.6 3.960.8 4.360.9 7.960.8**
HDL-C (mg/dL) 45.463.1 44.162.9 43.962.3 21.862.4 22.964.1 39.263.1**
LDL-C (mg/dL) 81.565.2 80.065.8 77.764.1 120.163.2 123.162.9 101.363.8**
Serum IGF-1 (ng/mL) 961.5687.6 920.9675.5 978.7654.9 160.9.1682.1 167.8689.1 607.3698.9**
Pancreas IGF-1 (ng/g wet tissue) 152.4650.2 142.2635.2 155.8625.8 51.1622.0 65.3625.1 120.1632.0**
Liver IGF-1 (ng/g wet tissue) 231.9613.9 240.5615.6 244.1619.0 85.9617.6 92.0616.7 165.1615.9*
Serum insulin (ng/mL) 4.960.08 5.160.07 5.260.08 0.360.08 0.3560.06 0.6260.07*
One-way ANOVA was performed to analyze the variation between 3 groups of non-diabetic or diabetic treatment. The data were then analyzed using Tukey’s multiples
comparison test (if parametric). Values were expressed as means6SEM. Differences between the PR-treated group and other diet groups were analyzed by Dunnet’s
multiple comparison test (*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0028693.t001
Bioactive Lipid in Pre-Germinated Brown Rice
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e28693To confirm the effect of PR-ASG on IGF-1 expression in INS-1
cells, mRNA expression was analyzed by RT-PCR. The mRNA
expression of IGF-1 was induced in the presence of serum.
Addition of PR-ASG revealed increased IGF-1 expression by INS-
1 cells after they were cultured with 4 and 8 mg/mL of PR-ASG
(Fig. 2C).
Insulin secretory response in INS-1 cells
When compared to a low glucose (2 mM) KRB buffer
(1.460.2 ng/mL per 1-hr culturing, mean 6SEM), a high glucose
(12 mM) KRB buffer produced a 8.5 –fold increase in glucose-
stimulated insulin secretion by INS-1 cells. PR-ASG did not alter
insulin secretion in the range of 0.4–40 mg/mL (data not shown).
IGF-1-dependent glucose utilization in INS-1 cells:
glycolytic pathway
The relevance of PR-ASG to IGF-1 in the glycolytic pathway
was ascertained by examining glucose utilization by INS-1 cells.
IGF-1-dependent glucose utilization via glycolysis including
uptake and consumption of extracellular glucose, was examined
by assessing the amount of glucose remaining in the cell-culture
medium. The glucose utilization by INS-1 cells was very low at
zero concentration of IGF-1, and showed less than 1.0 nmol
glucose/hr/10
6 cells. A higher range of IGF-1 treatment (10 to
300 ng/mL), however, produced dose-dependent glucose utiliza-
tion (Fig. 2B) with more than 70% (11.7 nmol glucose/hr/10
6
cells) of glucose consumed after exposure to 200–300 ng/mL of
Figure 1. Effect of serum and PR-ASG on cell viability and cell apoptosis under STZ treatment. A) Cells were exposed either to 1 mM STZ
(&) or to no STZ (%) in serum-free RPMI 1640 medium for 1 hr, followed by 2-day culturing either in serum-free (2) or in 10% serum (+) medium. The
treated cells were tested for viability using WST-8 assay. B) Cells were exposed for 1 hr either to 1 mM STZ (&) or to no STZ (%) in serum –free RPM
1640 medium supplemented with increasing amounts of PR-ASG (0–400 mg/mL). This was followed by 2 days of culturing in fresh serum-free
medium, again supplemented with increasing amounts of PR-ASG (0–400 mg/mL). The treated cells were tested for viability using WST-8 assay. Values
are expressed mean 6 SEM, with n=6 individual experiments. Data were analyzed by one-way ANOVA followed by Tukey’s test and then Dunnet’s
test. The multiple asterisks denote a statistically significant difference between the first column (non-shaded or shaded), as compared with each of
the other columns (non-shaded or shaded, respectively) (*p,0.05, **p,0.01, and ***p,0.001). C) Cells were exposed to STZ, serum, and PR-ASG.
They were then examined by TUNEL assay and nuclear staining (DAPI) with parameters described as follows: 2STZ (no STZ), +STZ(1 mM STZ),
2Serum (serum free), +Serum (10% serum), ASG1(400 mg/mL PR-ASG), and ASG2(4 mg/mL PR-ASG).
doi:10.1371/journal.pone.0028693.g001
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28693Figure 2. Effect of PR-ASG treatment on IGF-1 secretion, mRNA production, and glucose utilization in INS-1 cells. A) Cells were
exposed for 1 hr either to 1 mM STZ (&) or to no STZ (%) in serum-free RPMI 1640 medium supplemented with increasing amounts of PR-ASG (0–
40 mg/mL), followed by 2 days of culturing in fresh serum-free medium supplemented with increasing amounts of PR-ASG (0–40 mg/mL). Subsequently,
IGF-1 in the cell-conditioned medium was measured using IGF-1 assay kit. Values are expressed as mean 6 SEM, n=6 individual experiments. B) Cells
werepre-washedwithKrebs Ringerbuffer.They werethenculturedforonedaywithKrebsRingerbuffercontaining0.1 mMglucosesupplementedwith
increasing amount of IGF-1 (0–300 ng/mL), and either 4 mg/mL (&)o rn o( %) PR-ASG. Glucose utilization was examined in the supernatants of these
cells using a glucose assay kit. This glucose utilization was less than 1.0 nmol/hr/10
6 cells at zero concentration of IGF-1. A percent value denotes that
100% is equal to 16.7 nmol/hr per 10
6 cells. C) Cells (1.0610
7) were seeded in 10% serum- containing RPMI 1640 medium in a 100-mm dish that had
been precoated with 0.001% poly-L-ornithine. One day later, the cells were pre-washed twice using RPMI medium, followed by exposure either to 10%
serum or 0, 4, and 8 mg/mL of PR-ASG in serum-free medium. Two days later, RT-PCR was performed on the harvested cells as described in the Materials
and Methods section. D) Cells were exposed for 1 hr to 1 mM STZ in serum-free medium containing either 4 mg/mL PR-ASG or no PR-ASG. The treated
cells were washed with Krebs Ringer buffer. They were then cultured for one day with Krebs Ringer buffer containing 0.1 mM glucose supplemented
withIGF-1(0–300 ng/mL)andPR-ASG(&:4mg/mLor%:0mg/mL).Theglucoseutilizedwaslessthan 1.0 nmol/hr/10
6 cellsatzeroconcentrationofIGF-
1. E) Cells were pre-washed with Krebs Ringer buffer, followed by exposure for one day to PR-ASG (&:4mg/mL or %:0mg/mL) plus Krebs Ringer buffer
containing 0.1 mM glucose/300 ng/mL IGF-1 and increasing amounts of 2-DG (0–10 mM). In B), D), and E), glucose utilization was examined in the cell
supernatants using a glucose assay kit. Values were expressed as means 6 SEM, n=6 individual experiments and were analyzed by two-way ANOVA
followed by Bonferroni’s post test. The singular and multiple asterisks denote a statistically significant difference between non-shaded and shaded
columns at the same concentration of IGF-1 treatment (B, D) or 2-DG-treatment (E) (*p,0.05, **p,0.01).
doi:10.1371/journal.pone.0028693.g002
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served at 3 picogram levels of IGF-1 (8.562.1% for 200 pg/mL,
15.563.1% for 500 pg/mL, 18.063.1% for 1000 pg/mL, n=6,
respectively), corresponding to levels of IGF-1 secretion induced
by PR-ASG as shown in Fig. 2A. The presence of PR-ASG
showed a synergic effect on glucose utilization in relation to
exogenously added IGF-1, most significantly at 10 and 50 ng/
mL(**p,0.01), and 100 ng/mL(*p,0.05) of IGF-1. More than
80% utilization of glucose was observed at 200–300 ng/mL of
IGF-1.
STZ treatment suppressed the INS-1 cell response to IGF-1,
and decreased glucose consumption down to 50% at 300 ng/mL
of IGF-1 (Fig. 2D).
PR-ASG, however, protected cells from the negative effects of
STZ, showing statistically significant enhancement of glucose
utilization in response to IGF-1(**p,0.01 in 100 and 200 ng/mL
of IGF-1).
Treatment with 2-DG (0–10 mM) also inhibited the effect of
IGF-1 (300 ng/mL) on the INS-1 cells (Fig. 2E). Again, addition of
PR-ASG was observed to ameliorate and reverse the inhibition of
glucose utilization by 2-DG in a statistically significant manner on
the glyocolytic pathway (**p,0.01 in 1 and 5 mM 2-DG
treatment) (Fig. 2E).
Anti-oxidative stress by G6PD activity in INS-1 cells:
pentose phosphate pathway
The effect of PR-ASG on the pentose phosphate pathway was
examined by measuring G6PD activity in the cells. Non-treated
cells showed G6PD activity of 850 nmol formazan/hr/10
6 cells,
which was reduced to 550 nmol formazan/hr/10
6 cells by STZ
treatment.
The intracellular G6PD activity responded to changes in
extracellular glucose concentration, ranging from 2–32 mM
(Fig. 3A). Non-STZ-treated cells did not show a remarkable
enhancement of the pentose phosphate pathway, even with
addition of PR-ASG (4 mg/mL) (Fig. 3A). Although STZ-treated
cells showed relatively attenuated G6PD activity (550 nmol
formazan/hr/10
6 cells), mild enhancement of this activity was
observed in response to changes in extracellular glucose concen-
tration; furthermore, PR-ASG treatment of these cells showed a
further, statistically significant increase of G6PD activity at 16 mM
Glc (**p,0.01, Fig. 3B).
Treatment of the cells with Hcy produced a decrease in G6PD
activity (Fig. 3C). Again, PR-ASG reversed this influence of Hcy on
G6PD activity, with a statistical difference (**p,0.01 in 10 mM
Hcy treatment, *p,0.05 in 50 mM Hcy treatment, Fig. 3C),
suggesting normalization of the pentose phosphate pathway.
However, these beneficial effects of PR-ASG were eliminated with
10–100 mM 6-AN treatment, inhibiting G6PD activity regardless
of PR-ASG concentration with no statistical difference (Fig. 3D).
Oxidative stress and anti-oxidative stress in INS-1 cells:
ROS level and HTase activity
Cells were treated with STZ, and assessed for PR-ASG’s anti-
oxidative action. ROS staining demonstrated that STZ treatment
caused a highly elevated total ROS level in cells (Fig. 4A and B).
On the other hand, PR-ASG treatment reversed this effect and
decreased ROS production in cells by a statistical difference
(*p,0.01).
Under the condition of STZ-induced oxidative stress in the
absence of PR-ASG, cellular HTase activity was slightly
decreased, but not statistically different from the control group
(Fig. 4C). In the presence of PR-ASG, however, cellular HTase
activity showed statistically significant (*p,0.01) elevation in STZ-
treated cells in STZ-stressed under condition of oxidative stress.
Discussion
PR-ASG is a unique ingredient found in the bran of pre-
germinated brown rice that can be purified from the glycolipid
fractions, as previously reported [5]. In our current study, PR-diet
was tested in STZ-induced diabetic rats. Compared with diabetic
rats fed control diets, the PR-diet fed rats showed an improvement
of serum metabolic parameters including serum insulin levels and
peripheral NCV. This activity was considered to be derived from
PR-ASG, because of pancreatic IGF-1 elevation found in the
diabetic rats fed PR-diet. In addition, we confirmed that PR-ASG
shows an IGF-1-inducing effect on the pancreatic b-cell line, INS-
1 (834/40). Our cells demonstrated glucose-stimulated insulin
secretion, but not PR-ASG-stimulated insulin secretion. We
showed that this is a glucose-sensitive cell line that possesses the
potential ability to produce and release IGF-1 into the culture
medium [21].
STZ shows selective cytotoxicity on pancreatic b-cells, and thus
causes insulin-deficient diabetes. It has been suggested that STZ
may generate Reactive oxygen species (ROS) such as nitric oxide
(NO) and superoxide (O2
2), thereby inducing apoptosis of
pancreatic b-cells [22,23,24]. In our current study, PR-ASG
showed a protective effect similar to that of serum against STZ-
induced apoptosis (Fig. 1C). We are not sure whether this effect of
PR-ASG on STZ-treated INS-1 cells involves a cell proliferation
mechanism, as the growth factors are found in both serum and
tissues. We do however, report two significant findings of our
current study: 1) that pancreatic IGF-1 levels closer to normal
level, as compared with liver and serum levels, are remarkably
elevated in STZ-diabetic rats fed PR-ASG in an animal study
(Table 1); and 2) that PR-ASG-treated INS-1 cells produce and
release IGF-1 into the culture medium in our in vitro study (Fig. 2A
and C). Addition of serum to the medium resulted in IGF-1
mRNA expression by the INS-1 cells. This suggests that PR-ASG
is also related to cell proliferation via IGF-1 production and
secretion; although a remarkable level of cell proliferation has not
yet been observed according to PR-ASG treatment, as compared
with the remarkable cell proliferation level seen secondary to
serum treatment.
The primary defense system against oxidative stress in b-cells is
controlled by superoxide dismutase (SOD), glutathione peroxidase
(GSHPx), and catalase, which act to control ROS levels during
oxidative stress (Fig. 5). Maintenance of the redox status in cells is
controlled by intracellular regulators such as reduced glutathione
(GSH) and NADPH. This mechanism involves two enzymes:
glutathione reductase (GR) and glucose-6-phosphate dehydroge-
nase (G6PD). The overall effect of the antioxidant system depends
on the intraceullar balance between these antioxidant enzymes [6],
as a critical balance exists in the b-cells between endogenous ROS
generation and antioxidant defense. As expected, PR-ASG showed
an IGF-1-induced enhancement of glycolytic pathway in order to
overcome much of the STZ-induced oxidative stress (Fig. 2D).
In the antioxidant enzyme system, SOD’s role is to inactivate
ROS by catalyzing the O2
2 to H2O2, which is then further
metabolized to H2O and O2 by catalase and GSHPx (Fig. 5). We
demonstrated ROS elevation in the INS-1 cell by STZ-induced-
oxidative stress and ROS suppression by PR-ASG treatment
(Fig. 4A and B).
Extracellular SOD (EC-SOD) is sensitive to Hcy treatment. Hcy
subjects cells to additional oxidative stress by inhibiting the binding
of EC-SOD in fibroblasts [25] and endothelial cells [26].
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atic b-cells, it is suggested that HTase-related antioxidant control
is more important than ordinary defense for protection of EC-
SOD against the oxidative stress of Hcy. We also demonstrated a
change in HTase activity after PR-ASG treatment (Fig. 4C).
IGF-1 is ubiquitously distributed in various tissues and cells, and
it plays an important role for prevention of insulin resistance and
protection against age-related oxidative damage, leading to b-cell
apoptosis. In our study, the effect of STZ-induced diabetes has
been observed as a decrease in IGF-1 levels [27] (Table 1). The
glucose-dependent IGF-1 activation system is closely coupled to
glucose metabolism, glycolytic pathway, and the pentose phos-
phate pathway. The importance of G6PD activity in the pentose
phosphate pathway is to maintain the cellular ratio of NADPH/
NADP, and to up-regulate G6PD activity when required for the
cell apoptotic response to ROS [7,8]. The glycolytic pathway is
enhanced for cell proliferation subsequent to activation of the
glucose-dependent IGF-1 activation system [8]. IGF-1 is produced
and secreted by INS-1 cells secondary to treatment with PR-ASG,
although this mechanism is still unknown. Pyruvate, a metabolite
of the glycolytic pathway, is known to lessen oxidative stress by
scavenging H2O2 [28]. We have demonstrated that PR-ASG
affects IGF-1-induced-activation of glycolysis as the IGF-1-
dependent glucose utilization is blocked by 2-DG, a specific
Figure 3. Effect of PR-ASG on G6PD activity in the pentose phosphate pathway in INS-1 cells. A) Cells were treated for 30 min at 37uC
with serum-free RPMI-1640 medium containing glucose (0–32 mM) and PR-ASG (&;4mg/mL or %;0mg/mL). Subsequently, cells were trypsinized
and G6PD activity in the cell lysate was measured, as described in Materials and Methods. G6PD activity is expressed as a percent value, with 100%
equals to 850 nmol formazan/hr/10
6 cells. B) Cells were exposed for 1 hr to 1 mM STZ in RPMI1640 medium containing either 4 (&)o r0( %) mg/mL
of PR-ASG. Subsequently, cells were treated for 30 min at 37uC with serum-free RPMI-1640 medium containing increasing amounts of glucose (0–
32 mM) and either 4 (&)o r0( %) mg/mL of PR-ASG. The cells were then harvested, and the cell lysate was measured for G6PD activity, as described in
Materials and Methods section. In the condition of STZ-treatment, G6PD activity is expressed as a percent value, with 100% equal o 550 nmol
formazan/hr/10
6 cells. C) Cells were exposed for 24 hr to increasing amounts of Hcy (0–50 mM) in RPMI medium without folic acid and containing
either 4 (&)o r0 ( %) mg/mL of PR-ASG. Cultured cells were harvested, and assessed for G6PD activity, as described in Materials and Methods. G6PD
activity is expressed as a percent value, with 100% equal to 850 nmol formazan/hr/10
6 cells. D) Cells were exposed for 24 hr to increasing amounts of
6-AN (0–100 mM) in RPMI1640 medium containing either 4 (&)o r0( %) mg/mL of PR-ASG. The cells were then harvested and assessed for G6PD
activity, as described in Materials and Methods. G6PD activity is expressed as a percent value, with 100% equal to 850 nmol formazan/hr/10
6 cells. In
A), B), C), and D), values were presented as means 6 SEM, n=6 individual experiments and are analyzed by two-way ANOVA followed by Bonferroni’s
post test. The single and multiple asterisks denote a statistically significant difference between non-shaded and shaded columns at same
concentration of Glc treatment (A, B), Hcy treatment (C), or 6-AN treatment (D) (*p,0.05, **p,0.01).
doi:10.1371/journal.pone.0028693.g003
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the direct targets affected by PR-ASG were involved in the pentose
phosphate pathway. We also found that PR-ASG could not
ameliorate the effects of the pentose phosphate pathway inhibitor,
6-AN (Fig. 3D). It has been reported that hyperhomocysteinemia
led to significant lowering of G6PD activity [29]. It therefore
follows that Hcy treatment of INS-1 cells produced a decrease in
G6PD activity (Fig. 3C), presumably by a protein homocystinyla-
Figure 4. Effect of PR-ASG treatment on cellular ROS level and HTase activity in STZ-exposed cells. A) Initially, cells were incubated
under one of these sets of experimental parameters: STZ-negative, PR-ASG-negative (control); 1 mM STZ (STZ group); or 1 mM STZ supplemented
with 4 mg/mL of PR-ASG (STZ+PR-ASG). After 1 hr of incubation, the cells were pre-washed with fresh medium, stained with DCF-DA (1.0 mM), and
incubated in darkness for 10 min. DCF-DA green fluorescence was viewed under a fluorescence microscope. B) DCF-DA green fluorescing cells were
also quantitated by a Perkin-Elmer Victor V multilabel plate reader with excitation/emission filters set at 490 and 535 nm, and expressed as the
percent of the total number of cells that exhibit DCA-DA green fluorescence. C) Cells (2.5610
5 in 1 mL of 10% serum- containing RPMI 1640 medium
well) were cultured in12-well plates. One day later, the cells were divided into 3 groups fro 1 hour of exposure to one of the following in RPMI
medium containing 1.0 mg/mL rat LDL; no STZ with no PR-ASG (control); 1 mM STZ (STZ); or 1 mM STZ with 4 mg/mL of PR-ASG (STZ+PR-ASG).
Subsequently, cells were pre-washed; cultured for 24 hours in serum-free RPMI-1640 medium with 0 or 4 mg/mL of PR-ASG; harvested; and eventually
used for enzyme preparation. The cellular supernatant produced during enzyme preparation was assessed for activity using an Alfresa auto HTLase
assay kit (Alfresa Pharma Corp., Osaka, Japan). One unit of HTase activity is defined as 1 nmol of HT hydrolyzed in 1 min by 1 mg of protein. In B) and
C), values were expressed as means 6 SEM, n=6 individual experiments, and analyzed by one-way ANOVA followed by Tukey’s multiples comparison
test and then Dunnet’s test. The single asterisk denotes a statistically significant difference between STZ and STZ+PR-ASG (*p,0.01).
doi:10.1371/journal.pone.0028693.g004
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cells showed an ameliorating decrease of G6PD activity by Hcy
treatment, indirectly regulating the pentose phosphate pathway.
We also demonstrated cellular HTase activity was decreased by
STZ-stress and recovered by PR-ASG (Fig. 4C).
In summary, our findings suggest that the PR-diet markedly
reduced hyperglycemia and peripheral neuropathy in STZ-induced
diabetic rats; and that this reduction was due to increased IGF-1
secretion and anti-oxidative stress enzyme HTase activation. The
animal results supported our other evidence in showing that PR-
ASG acts on INS-1 cells through both an IGF-1-dependent
mechanism, and an HTase activation mechanism of ameliorating
decreased glycolysis activity in oxidatively stressed cells.
It is therefore collectively suggested that PR-ASG may protect
pancreatic b-cells via enhancement of an IGF-1 dependent
autocrine system, leading to subsequent activation of an IGF-1
dependent–defense system, which, together with HTase activation,
may be useful in the treatment of oxidative stress and its
complications in diabetes.
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